Product
PIKA COVID-19 Vaccine
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Adults Who is COVID-19 naïve or Had Previous COVID-19 Infection or Completed Inactivated or mRNA COVID-19 Vaccination.Status: Completed, Estimated PCD: 2022-05-15